Ftse Mib
33.494,83
0,60%
DAX
19.322,59
0,91%
S&P 500
5.969,34
0,35%
NASDAQ
19.003,65
0,16%
Bitcoin
98.130,35
0,35%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Sonnet BioTherapeutics Holdings Inc (SONN) Sonnet BioTherapeutics Holdings Inc (SONN) Notizie

Sonnet BioTherapeutics Holdings Inc

SONN
2,98
0,09 (3,11%)
23 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
12/11/202415:15GLOBESonnet BioTherapeutics Releases Virtual Investor ‘”What this..
08/11/202414:30EDGAR2Form 8-K - Current report
07/11/202415:22EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
07/11/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
06/11/202419:20GLOBESonnet BioTherapeutics Announces Pricing of $5.0 Million..
06/11/202415:22EDGAR2Form S-1/A - General form for registration of securities..
06/11/202414:48EDGAR2Form 8-K - Current report
06/11/202414:30GLOBESonnet BioTherapeutics Announces Issuance of U.S. Patent..
04/11/202415:01EDGAR2Form S-1/A - General form for registration of securities..
28/10/202414:01EDGAR2Form S-1 - General form for registration of securities under..
17/10/202414:50EDGAR2Form 8-K - Current report
17/10/202414:45GLOBESonnet BioTherapeutics Inc. Regains Compliance with Nasdaq
09/10/202414:56EDGAR2Form 8-K - Current report
09/10/202414:45GLOBESonnet BioTherapeutics Inc. Enters into Licensing Agreement..
04/10/202414:30GLOBESonnet BioTherapeutics to Receive Non-Dilutive Funding..
30/9/202415:00GLOBESonnet BioTherapeutics Announces Launch of CEO Corner..
30/9/202414:30EDGAR2Form 8-K - Current report
25/9/202414:30GLOBESonnet BioTherapeutics Announces 1-for-8 Reverse Stock Split
18/9/202414:36EDGAR2Form 8-K - Current report
18/9/202414:30GLOBESonnet BioTherapeutics Completes Enrollment in Phase 1 Study..
12/9/202423:15EDGAR2Form 8-K - Current report
09/9/202422:08EDGAR2Form 8-K - Current report
04/9/202415:15GLOBESonnet BioTherapeutics to Participate in the Virtual..
30/8/202414:30EDGAR2Form 8-K - Current report
19/8/202423:27EDGAR2Form DEF 14A - Other definitive proxy statements
19/8/202414:50EDGAR2Form 8-K - Current report
19/8/202414:45GLOBESonnet BioTherapeutics Enters into Clinical Collaboration..
14/8/202414:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202414:41EDGAR2Form 8-K - Current report
14/8/202414:35GLOBESonnet BioTherapeutics Reports Third Quarter Fiscal Year..
09/8/202423:28EDGAR2Form PRE 14A - Other preliminary proxy statements
09/8/202422:05EDGAR2Form 8-K - Current report
24/7/202414:36EDGAR2Form 8-K - Current report
24/7/202414:30GLOBESonnet BioTherapeutics Reports Encouraging Data from Phase..
15/7/202423:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
20/6/202414:30GLOBESonnet BioTherapeutics Announces Exercise of Warrants for..
13/6/202414:15EDGAR2Form 8-K - Current report
13/6/202414:00GLOBESonnet BioTherapeutics Announces the Generation and..
28/5/202414:00GLOBESonnet BioTherapeutics to Present SB221 as a Trial in..
22/5/202413:35EDGAR2Form 8-K - Current report
20/5/202415:25EDGAR2Form 8-K - Current report
16/5/202422:16EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/5/202422:06EDGAR2Form S-1/A - General form for registration of securities..
14/5/202423:25EDGAR2Form 8-K - Current report
14/5/202423:07EDGAR2Form 8-K - Current report
14/5/202422:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/3/202412:30EDGAR2Form 8-K - Current report
14/2/202413:35EDGAR2Form 8-K - Current report
14/2/202413:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/2/202422:20EDGAR2Form 8-K - Current report
Apertura: 2,99 Min: 2,88 Max: 3,00
Chiusura: 2,89

La tua Cronologia

NASDAQ
SONN
Sonnet BioTherapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network